The Global Diabetes Treatment Devices Market to reach a value of US$ 16,706.4 Mn from US$ 10,826.6 Mn. The forecast period is set from 2018 to 2026, and the market is expected to grow at a CAGR of 5.6%. All information related to the market is provided in the report, titled,” Diabetes Treatment Devices Market Size, Share and Global Trend by Product (Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others), By Distribution Channel (Institutional Sales (Hospitals, Clinics), Retail Sales (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)) & Geography Forecast till 2026”. The rising prevalence of diabetes on worldwide basis is the main factors propelling growth of the diabetes treatment devices market.
The report covers:
- Global Diabetes Treatment Devices Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/diabetes-treatment-devices-market-100777
Leading Players operating in the Diabetes Treatment Devices Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Hoffmann-La Roche Ltd.
- Tandem Diabetes Care, Inc.
- BD, Eli Lilly
Asia Pacific to Emerge Dominant on Account of Mass Patient Pool
Fortune Business Insights foresees the global diabetes treatment devices market to be dominated by Asia Pacific. This is likely to remain the same in the forecast duration as well owing to the rising geriatric population and their susceptibility towards various diseases especially diabetes and heart problems. In 2018, Asia Pacific generated a revenue of US$ 4,334.8 Mn owing to the increasing adoption of advanced insulin device for treating diabetes.
The American Diabetes Association published an article stating 60% people in Asia Pacific live with diabetes out of which one-half is registered by China and India together. The huge patient pool for diabetes is a major factor promoting growth of the global diabetes treatment device market in the coming years.
- Insulin Pens
- Insulin Pumps
- Insulin Jet Injectors
- Insulin Syringes
By Distribution Channel
- Institutional Sales
- Retail Sales
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies